Sep 24, 2020
Today's Business as Usual, will feature one of Pittsburgh's top life sciences companies -- Knopp Biosciences. President and CEO Michael Bozik will detail how the vision of Knopp is to change the course of human health. It targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetic testing. Knopp is also committed to expanding the drug discovery and development industry in western Pennsylvania. The Pittsburgh area is home to some of the nation's most significant and well-funded research institutions, creating a favorable environment for the biopharma industry. Bozik will explain how Knopp plays an important role in expanding the region’s capabilities and reputation as a premier location for bioscience commercialization.